S

Similasan

Similasan agreed to pay $3.575 million to settle claims that its homeopathic eye drops were deceptively labeled and advertised.

ClosedUnited States-wideClaim status: Closed on October 15, 2025Payout: VariesNo longer claimable

About this settlement

The case addresses deceptive labeling and advertising of homeopathic eye drops sold by Similasan and retailers.

This settlement resolves claims that Similasan's homeopathic eye drops were deceptively labeled and advertised. Eligible consumers who purchased certain Similasan, CVS, or Walgreens eye drop products during the specified period may submit claims for compensation.

Who qualifies

  • Consumers who purchased specified Similasan, CVS, or Walgreens eye drop products.
  • Purchases made between September 11, 2017 and February 20, 2025.

Varies

Claim status: Closed on October 15, 2025

See active Settlements

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

96 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

746 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon